Literature DB >> 1528650

Fatal Chromobacterium violaceum infections associated with exposure to stagnant waters.

R Ponte1, S G Jenkins.   

Abstract

Entities:  

Mesh：

Year:  1992        PMID： 1528650     DOI： 10.1097/00006454-199207000-00013

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


× No keyword cloud information.
  11 in total

1.  Chromobacterium violaceum infections in 13 non-human primates.

Authors:  David X Liu; Peter J Didier; Gail B Plauche
Journal:  J Med Primatol       Date:  2011-12-29       Impact factor: 0.667

2.  Two cases of Chromobacterium violaceum infection after injury in a subtropical region.

Authors:  J Lee; J S Kim; C H Nahm; J W Choi; J Kim; S H Pai; K H Moon; K Lee; Y Chong
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

3.  Two siblings with fatal Chromobacterium violaceum sepsis linked to drinking water.

Authors:  Salman Mohammed Al Khalifa; Turki Al Khaldi; Manaf Mohammed Alqahtani; Ahmed Mohamed Al Ansari
Journal:  BMJ Case Rep       Date:  2015-08-30

4.  Urinary tract infection by chromobacterium violaceum.

Authors:  Bichitrananda Swain; Sarita Otta; Kundan Kumar Sahu; Kirtika Panda; Subhrajita Rout
Journal:  J Clin Diagn Res       Date:  2014-08-20

5.  Agricultural Injury-Associated Chromobacterium violaceum Infection in a Bangladeshi Farmer.

Authors:  Razib Mazumder; Tuhin Sadique; Debashis Sen; Palash Mozumder; Tania Rahman; Anup Chowdhury; Farhana Halim; Nasrin Akter; Dilruba Ahmed
Journal:  Am J Trop Med Hyg       Date:  2020-09       Impact factor: 2.345

6.  Chromobacterium violaceum in siblings, Brazil.

Authors:  Isadora Cristina de Siqueira; Juarez Dias; Hilda Ruf; Eduardo Antonio G Ramos; Elves Anderson Pires Maciel; Ana Rolim; Laura Labur; Luciana Vasconcelos; Célia Silvany
Journal:  Emerg Infect Dis       Date:  2005-09       Impact factor: 6.883

7.  Urinary tract infection caused by Chromobacterium violaceum.

Authors:  Narayan Dutt Pant; Manisha Sharma
Journal:  Int J Gen Med       Date:  2015-09-10

8.  Chromobacterium Violaceum Sepsis: Rethinking Conventional Therapy to Improve Outcome.

Authors:  Kathleen R Richard; Joshua J Lovvorn; Sara E Oliver; Shannon A Ross; Kim W Benner; Michele Y F Kong
Journal:  Am J Case Rep       Date:  2015-10-19

Review 9.  Chromobacterium violaceum: A Review of an Unexpected Scourge.

Authors:  Bachti Alisjahbana; Josephine Debora; Evan Susandi; Guntur Darmawan
Journal:  Int J Gen Med       Date:  2021-07-09

10.  Antiplasmodial and trypanocidal activity of violacein and deoxyviolacein produced from synthetic operons.

Authors:  Elizabeth Bilsland; Tatyana A Tavella; Renata Krogh; Jamie E Stokes; Annabelle Roberts; James Ajioka; David R Spring; Adriano D Andricopulo; Fabio T M Costa; Stephen G Oliver
Journal:  BMC Biotechnol       Date:  2018-04-11       Impact factor: 2.563
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.